Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
Clinical trial NCT04291209 · UNKNOWN
Trial details
- NCT number
- NCT04291209
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2024-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.